Stockreport

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock [TheStreet.com]

Lucid Diagnostics Inc.  (LUCD) 
PDF NEW YORK, April 23, 2026 NEW YORK April 23, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer preventi [Read more]